| RS1555743845 |
ASXL3
|
Health Risk |
Likely pathogenic |
— |
| RS1555743942 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555743954 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1555744039 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1555744086 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1555744175 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1555744178 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, ASXL3-related disorder |
| RS1555744217 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS1555744253 |
LTBP4
|
Health Risk |
Pathogenic |
— |
| RS1555744282 |
ASXL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1555744396 |
ASXL3
|
Health Risk |
Pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1555744805 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555744812 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555744989 |
ASXL3
|
Health Risk |
Likely pathogenic |
— |
| RS1555745158 |
CACNA1A;LOC126862864
|
Health Risk |
Likely pathogenic |
— |
| RS1555745207 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555745215 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS1555745263 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555745317 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555745461 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
CACNA1A-associated disorders, Delayed gross motor development |
| RS1555745467 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
CACNA1A-related disorder, Episodic ataxia type 2 |
| RS1555745616 |
ASXL3
|
Health Risk |
Likely pathogenic |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome, Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome |
| RS1555745989 |
ATP5F1D
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial complex V (ATP synthase) deficiency |
| RS1555746079 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555746859 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Rabson-Mendenhall syndrome, Rabson-Mendenhall syndrome |
| RS1555747776 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1555748498 |
PNPLA6
|
Health Risk |
Pathogenic |
— |
| RS1555748534 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1555748556 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1555748926 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1555748940 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS1555749239 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1555749369 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555749434 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555749683 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1555749853 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1555749927 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555750535 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555750542 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555750580 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555750642 |
ERF
|
Health Risk |
Likely pathogenic |
— |
| RS1555750721 |
ERF
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555750741 |
ERF
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, TWIST1-related craniosynostosis |
| RS1555750795 |
ERF
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, Inborn genetic diseases |
| RS1555750816 |
ERF
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, Lambdoidal craniosynostosis |
| RS1555751089 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1555751109 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555751240 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555751336 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS1555751379 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555751423 |
LAMA3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555751482 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555751529 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555751597 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1555751762 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1555751995 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1555752083 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555752113 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555752859 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555752975 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1555753042 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1555753569 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS1555753627 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555753680 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555753690 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555753732 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555753773 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555754177 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1555754185 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555754293 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555754450 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1555754655 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Thyroid cancer |
| RS1555754744 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1555755067 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555755242 |
TGFB1
|
Health Risk |
Likely pathogenic |
Inflammatory bowel disease, immunodeficiency |
| RS1555755308 |
TGFB1
|
Health Risk |
Likely pathogenic |
Encephalopathy, IL10-related early-onset inflammatory bowel disease |
| RS1555755878 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia type 6, Spinocerebellar ataxia type 6 |
| RS1555755909 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555755926 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1555755929 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1555755977 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1555756091 |
CACNA1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555756130 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1555756161 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1555756257 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1555756326 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555756461 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555756737 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1555757432 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1555757523 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555757537 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1555757738 |
SMARCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1555758035 |
CRLF1
|
Health Risk |
Pathogenic |
Cold-induced sweating syndrome 1, Cold-induced sweating syndrome 1 |
| RS1555758163 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555758842 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555758856 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555759066 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1555759089 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1555760738 |
CALR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary myelofibrosis, Thrombocythemia 1 |
| RS1555761603 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |